Jim Simons Navidea Biopharmaceuticals, Inc. Transaction History

Renaissance Technologies LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.24 - $0.34 $41,472 - $58,752	172,800 Added 264.49%	238,133 $62,000
Q4 2022 Feb 13, 2023	BUY	$0.18 - $0.3 $7,110 - $11,850	39,500 Added 152.91%	65,333 $14,000
Q3 2022 Nov 14, 2022	BUY	$0.24 - $0.71 $3,168 - $9,372	13,200 Added 104.49%	25,833 $7,000
Q2 2022 Aug 12, 2022	BUY	$0.63 - $1.1 $7,958 - $13,896	12,633 New	12,633 $9,000
Q2 2021 Aug 13, 2021	SELL	$1.55 - $2.15 $204,007 - $282,978	-131,618 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$1.99 - $2.9 $151,086 - $220,176	75,923 Added 136.32%	131,618 $266,000
Q4 2020 Feb 10, 2021	SELL	$1.88 - $2.84 $76,051 - $114,886	-40,453 Reduced 42.07%	55,695 $120,000
Q3 2020 Nov 13, 2020	SELL	$2.69 - $4.95 $411,171 - $756,617	-152,852 Reduced 61.39%	96,148 $260,000
Q2 2020 Aug 13, 2020	BUY	$0.7 - $4.16 $174,300 - $1.04 Million	249,000 New	249,000 $981,000

10.4K

Ticker NAVB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,150,900
Description
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through two segments, Diagnostic Substances and Therapeutic Development Programs. The company develops Manocept platform to target the CD206 mannose receptor expr...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.